MetLife Investment Management’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.28M | Hold |
34,727
| – | – | 0.01% | 1186 |
|
2025
Q1 | $1.36M | Sell |
34,727
-495
| -1% | -$19.4K | 0.01% | 1223 |
|
2024
Q4 | $1.64M | Buy |
35,222
+1,987
| +6% | +$92.3K | 0.01% | 1156 |
|
2024
Q3 | $1.5M | Hold |
33,235
| – | – | 0.01% | 1172 |
|
2024
Q2 | $1.64M | Buy |
33,235
+3,189
| +11% | +$157K | 0.01% | 1072 |
|
2024
Q1 | $1.03M | Buy |
30,046
+356
| +1% | +$12.2K | 0.01% | 1282 |
|
2023
Q4 | $1.09M | Hold |
29,690
| – | – | 0.01% | 1245 |
|
2023
Q3 | $602K | Hold |
29,690
| – | – | ﹤0.01% | 1514 |
|
2023
Q2 | $607K | Hold |
29,690
| – | – | ﹤0.01% | 1569 |
|
2023
Q1 | $448K | Hold |
29,690
| – | – | ﹤0.01% | 1708 |
|
2022
Q4 | $707K | Hold |
29,690
| – | – | 0.01% | 1412 |
|
2022
Q3 | $1.05M | Hold |
29,690
| – | – | 0.01% | 1165 |
|
2022
Q2 | $1.04M | Hold |
29,690
| – | – | 0.01% | 1188 |
|
2022
Q1 | $1.47M | Buy |
29,690
+13,308
| +81% | +$657K | 0.01% | 1127 |
|
2021
Q4 | $1.27M | Hold |
16,382
| – | – | 0.01% | 1032 |
|
2021
Q3 | $1.75M | Sell |
16,382
-1,060
| -6% | -$113K | 0.02% | 919 |
|
2021
Q2 | $2.32M | Hold |
17,442
| – | – | 0.02% | 817 |
|
2021
Q1 | $2.16M | Buy |
17,442
+3,997
| +30% | +$495K | 0.02% | 836 |
|
2020
Q4 | $1.9M | Hold |
13,445
| – | – | 0.02% | 854 |
|
2020
Q3 | $1.02M | Hold |
13,445
| – | – | 0.01% | 1015 |
|
2020
Q2 | $609K | Buy |
13,445
+1,813
| +16% | +$82.1K | 0.01% | 1274 |
|
2020
Q1 | $356K | Buy |
11,632
+1,390
| +14% | +$42.5K | ﹤0.01% | 1395 |
|
2019
Q4 | $215K | Hold |
10,242
| – | – | ﹤0.01% | 1939 |
|
2019
Q3 | $245K | Hold |
10,242
| – | – | ﹤0.01% | 1829 |
|
2019
Q2 | $297K | Buy |
+10,242
| New | +$297K | ﹤0.01% | 1793 |
|